Nitroglycerin and Tadalafil Interaction

Drug interaction information between Nitroglycerin and Tadalafil.

Nitroglycerin and Tadalafil have a documented minor interaction in FDA labeling.

FDA drug labeling documents a minor-severity interaction between Nitroglycerin and Tadalafil. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Nitroglycerin

Nitrate Vasodilator

Drug B

Tadalafil

PDE5 Inhibitor

How They Interact

Tadalafil makes the blood-pressure-lowering effects of nitroglycerin much stronger. This can lead to a severe and unsafe decrease in your blood pressure.

FDA Label Information

PDE-5-Inhibitors such as avanafil, sildenafil, vardenafil, and tadalafil have been shown to potentiate the hypotensive effects of organic nitrates.

Frequently Asked Questions

What SPL severity band is on file for Nitroglycerin + Tadalafil?

Compiled FDA labeling labels this pair minor. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Tadalafil has 25 labeled pairs on file vs Nitroglycerin's 8. In the minor band specifically: Nitroglycerin has 6 (also Aspirin, Sildenafil, Heparin, Isradipine); Tadalafil has 22 (also Amlodipine, Metoprolol, Tamsulosin, Aspirin).

What mechanism field is on file for Nitroglycerin and Tadalafil?

Tadalafil makes the blood-pressure-lowering effects of nitroglycerin much stronger. This can lead to a severe and unsafe decrease in your blood pressure.

Tadalafil carries more major-labeled pairs than Nitroglycerin

SPL source-record counts only. This page's band is minor · classes on file: Nitroglycerin (Nitrate Vasodilator); Tadalafil (PDE5 Inhibitor).

Tadalafil has 1 major-labeled pair vs Nitroglycerin's 0. This page itself is in the minor band, not the major band.

Nitroglycerin

0 major · 2 moderate · 6 minor · 8 total

Tadalafil

1 major · 2 moderate · 22 minor · 25 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.